Log In
Print this Print this

NDV-3A (formerly NDV-3)

  Manage Alerts
Collapse Summary General Information
Company NovaDigm Therapeutics Inc.
DescriptionProphylactic vaccine containing the recombinant N-terminus of the Candida surface protein agglutinin-like protein fragment 3 (ALS3)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today